Literature DB >> 21519246

Renal disease in HIV-infected individuals.

John Phair1, Frank Palella.   

Abstract

PURPOSE OF REVIEW: Highly active antiretroviral therapy (HAART) has resulted in a marked decrease in AIDS-related conditions and death. With improved survival, cardiovascular disease, hepatic, renal disease, and non-AIDS-related cancers represent an increasing burden for HIV-infected individuals. RECENT
FINDINGS: HIV-associated nephropathy (HIVAN), acute renal injury, HAART, and comorbid conditions such as hepatitis C, hypertension, and diabetes are among the multiple causes of renal disease. In HIVAN there is incomplete understanding of the interaction of the virus with renal cells and the host genetics leading to susceptibility to this form of renal dysfunction. There is agreement that a baseline estimated glomerular filtration should be obtained and that renal function should be monitored during antiretroviral therapy. There is, however, no agreement as to the most accurate method of estimating GFR. Renal transplantation has emerged as a feasible and successful modality of management of end-stage renal disease (ESRD) in HIV-infected individuals.
SUMMARY: Kidney disease represents an increasing concern in the care of HIV-infected persons, although there are questions remaining regarding the pathophysiology of HIVAN. Transplantation, however, can be carried out safely in infected persons with ESRD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21519246      PMCID: PMC3266688          DOI: 10.1097/COH.0b013e3283476bc3

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  45 in total

1.  Tackling the unknowns in HIV-related kidney diseases.

Authors:  Lynda Anne Szczech
Journal:  N Engl J Med       Date:  2010-11-18       Impact factor: 91.245

2.  Classification of chronic kidney disease: a step forward.

Authors:  Andrew S Levey; Navdeep Tangri; Lesley A Stevens
Journal:  Ann Intern Med       Date:  2011-01-04       Impact factor: 25.391

3.  Long-term clinical consequences of acute kidney injury in the HIV-infected.

Authors:  Andy I Choi; Yongmei Li; Chirag Parikh; Paul A Volberding; Michael G Shlipak
Journal:  Kidney Int       Date:  2010-06-02       Impact factor: 10.612

4.  Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study.

Authors:  Marcello Tonelli; Paul Muntner; Anita Lloyd; Braden J Manns; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Brenda R Hemmelgarn
Journal:  Ann Intern Med       Date:  2011-01-04       Impact factor: 25.391

5.  Outcomes of kidney transplantation in HIV-infected recipients.

Authors:  Peter G Stock; Burc Barin; Barbara Murphy; Douglas Hanto; Jorge M Diego; Jimmy Light; Charles Davis; Emily Blumberg; David Simon; Aruna Subramanian; J Michael Millis; G Marshall Lyon; Kenneth Brayman; Doug Slakey; Ron Shapiro; Joseph Melancon; Jeffrey M Jacobson; Valentina Stosor; Jean L Olson; Donald M Stablein; Michelle E Roland
Journal:  N Engl J Med       Date:  2010-11-18       Impact factor: 91.245

6.  Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).

Authors:  Pierre De Beaudrap; Mouhamadou Baila Diallo; Roland Landman; Ndeye Fatou Guèye; Ibrahima Ndiaye; Assane Diouf; Coumba Toure Kane; Jean-Francois Etard; Pierre-Marie Girard; Papa Salif Sow; Eric Delaporte
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09-21       Impact factor: 2.205

7.  Non-productive HIV-1 infection of human glomerular and urinary podocytes.

Authors:  Atanu K Khatua; Harry E Taylor; James E K Hildreth; Waldemar Popik
Journal:  Virology       Date:  2010-12-05       Impact factor: 3.616

8.  Kidney function and the risk of cardiovascular events in HIV-1-infected patients.

Authors:  Elizabeth George; Gregory M Lucas; Girish N Nadkarni; Derek M Fine; Richard Moore; Mohamed G Atta
Journal:  AIDS       Date:  2010-01-28       Impact factor: 4.177

9.  Kidney diseases in HIV/HCV-co-infected patients.

Authors:  Hassane Izzedine; Damien Sene; Patrice Cacoub; Helena Jansen; Laurent Camous; Isabelle Brocheriou; Edward Bourry; Gilbert Deray
Journal:  AIDS       Date:  2009-06-19       Impact factor: 4.177

10.  Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.

Authors:  Pablo Labarga; Pablo Barreiro; Luz Martin-Carbonero; Sonia Rodriguez-Novoa; Carmen Solera; Jose Medrano; Pablo Rivas; Marta Albalater; Francisco Blanco; Victoria Moreno; Eugenia Vispo; Vincent Soriano
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

View more
  28 in total

1.  Association of tenofovir exposure with kidney disease risk in HIV infection.

Authors:  Rebecca Scherzer; Michelle Estrella; Yongmei Li; Andy I Choi; Steven G Deeks; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

Review 2.  HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment.

Authors:  Avi Z Rosenberg; Saraladevi Naicker; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2015-02-17       Impact factor: 28.314

Review 3.  Renal dysfunction in the setting of HIV/AIDS.

Authors:  Jose M Miro; Federico Cofan; Joan C Trullas; Christian Manzardo; Carlos Cervera; Montserrat Tuset; Federico Oppenheimer; Mercedes Brunet; Asuncion Moreno; Josep M Campistol; Jose M Gatell
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

4.  Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma.

Authors:  Katsushi Tajima; Kei Kohno; Yosuke Shiono; Ikuko Suzuki; Yuichi Kato; Yuki Hiroshima; Masakazu Yamamoto; Hiroya Ohtake; Akiko Iwaba; Mitsunori Yamakawa; Takeo Kato
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

5.  Temporal trends in critical events complicating HIV infection: 1999-2010 multicentre cohort study in France.

Authors:  François Barbier; Antoine Roux; Emmanuel Canet; Patricia Martel-Samb; Philippe Aegerter; Michel Wolff; Bertrand Guidet; Elie Azoulay
Journal:  Intensive Care Med       Date:  2014-09-19       Impact factor: 17.440

6.  Prevalence of renal disease within an urban HIV-infected cohort in northern Italy.

Authors:  Leonardo Calza; Elisa Vanino; Eleonora Magistrelli; Caterina Salvadori; Alessandra Cascavilla; Vincenzo Colangeli; Maria Assunta Di Bari; Roberto Manfredi; Pierluigi Viale
Journal:  Clin Exp Nephrol       Date:  2013-05-28       Impact factor: 2.801

7.  HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.

Authors:  Kaku A So-Armah; Joyce Chang; Charles Alcorn; Vincent Lo Re; Jason V Baker; Russell Tracy; Adeel A Butt; Brian K Agan; David Rimland; Cynthia L Gibert; Matthew B Goetz; Krisann K Oursler; Maria C Rodriguez-Barradas; Lewis H Kuller; Sheldon T Brown; James H Stein; Melissa Skanderson; Amy C Justice; Matthew S Freiberg
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

8.  Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans.

Authors:  Kaku A Armah; Chung-Chou H Chang; Jason V Baker; Vasan S Ramachandran; Matthew J Budoff; Heidi M Crane; Cynthia L Gibert; Matthew B Goetz; David A Leaf; Kathleen A McGinnis; Krisann K Oursler; David Rimland; Maria C Rodriguez-Barradas; Jason J Sico; Alberta L Warner; Priscilla Y Hsue; Lewis H Kuller; Amy C Justice; Matthew S Freiberg
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

9.  Dipstick urinalysis should be documented prior to initiating antiretroviral therapy.

Authors:  Tubonye C Harry
Journal:  Niger Med J       Date:  2012-01

10.  Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.

Authors:  Sang Hoon Han; Seung Up Kim; Chang Oh Kim; Su Jin Jeong; Jun Yong Park; Jun Yong Choi; Do Young Kim; Sang Hoon Ahn; Young Goo Song; Kwang-Hyub Han; June Myung Kim
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.